Cenevo has launched the Labguru Customer Portal, a digital platform that integrates with ELN and LIMS systems to centralize workflows and provide real-time project visibility for CROs, CDMOs, and diagnostic labs.
The AMA has approved a new PLA CPT code, effective July 1, 2026, to support claims processing and clinical adoption in CNS metastases diagnostics.
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
The accreditation covers liver health diagnostics, including Hepatotrack, a molecular diagnostic liquid biopsy that is predictive of acute liver rejection post-liver transplant.
The owner of an Oregon clinical laboratory allegedly submitted tens of millions in fraudulent claims to Medicare Advantage plans for laboratory testing services that were never ordered or performed.
Lot-to-lot reagent inconsistencies can have significant effects on patient test results.
The blood-based genomic profiling assay for advanced solid tumors is now reimbursable under Medicare’s policy covering plasma-based genomic profiling tests.
Analysis of international surveillance data shows rising resistance to last-line antibiotics, with significant regional variations in treatment outcomes.